[Myocardial Revascularization in Patients With Chronic Ischemic Heart Disease Combined With Chronic Obstructive Pulmonary Disease]. 2016

V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
1Kuban State Medical University, Krasnodar, Russia; 2Central Hospital of Oilworkers, Baku, Azerbaijan; 3Scientific and Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan.

Currently enough data has been accumulated to consider chronic obstructive pulmonary disease (COPD) as one of important factors of poor prognosis in patients with coronary artery disease, possibly producing an impact on perioperative risk during coronary artery bypass grafting surgery and percutaneous coronary interventions, as well as on long-term outcomes of these procedures. In this review we have analyzed studies which attempted to assess COPD as a factor that can affect outcomes of myocardial revascularization.

UI MeSH Term Description Entries
D009204 Myocardial Revascularization The restoration of blood supply to the myocardium. (From Dorland, 28th ed) Internal Mammary Artery Implantation,Myocardial Revascularizations,Revascularization, Myocardial,Revascularizations, Myocardial
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017202 Myocardial Ischemia A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION). Heart Disease, Ischemic,Ischemia, Myocardial,Ischemic Heart Disease,Disease, Ischemic Heart,Diseases, Ischemic Heart,Heart Diseases, Ischemic,Ischemias, Myocardial,Ischemic Heart Diseases,Myocardial Ischemias
D062645 Percutaneous Coronary Intervention A family of percutaneous techniques that are used to manage CORONARY OCCLUSION, including standard balloon angioplasty (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY), the placement of intracoronary STENTS, and atheroablative technologies (e.g., ATHERECTOMY; ENDARTERECTOMY; THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY). PTCA was the dominant form of PCI, before the widespread use of stenting. Percutaneous Coronary Revascularization,Coronary Intervention, Percutaneous,Coronary Interventions, Percutaneous,Coronary Revascularization, Percutaneous,Coronary Revascularizations, Percutaneous,Intervention, Percutaneous Coronary,Interventions, Percutaneous Coronary,Percutaneous Coronary Interventions,Percutaneous Coronary Revascularizations,Revascularization, Percutaneous Coronary,Revascularizations, Percutaneous Coronary
D029424 Pulmonary Disease, Chronic Obstructive A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA. Airflow Obstruction, Chronic,COAD,COPD,Chronic Airflow Obstruction,Chronic Obstructive Airway Disease,Chronic Obstructive Lung Disease,Chronic Obstructive Pulmonary Disease,Chronic Obstructive Pulmonary Diseases,Airflow Obstructions, Chronic,Chronic Airflow Obstructions

Related Publications

V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
January 1999, Terapevticheskii arkhiv,
V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
January 2003, Advances in gerontology = Uspekhi gerontologii,
V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
January 2009, Klinicheskaia meditsina,
V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
January 2010, Terapevticheskii arkhiv,
V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
January 1998, International journal of cardiovascular interventions,
V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
December 2004, Likars'ka sprava,
V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
September 1989, Khirurgiia,
V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
January 2003, Cirugia y cirujanos,
V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
January 2013, Kardiologiia,
V K Zafiraki, and K V Skaletsky, and E D Kosmacheva, and L V Shulzhenko, and J M Ramazanov, and A A Omarov
January 1997, Meditsinskaia tekhnika,
Copied contents to your clipboard!